Cervical metastasis of occult papillary thyroid carcinoma associated with epidermoid carcinoma of the larynx.
ABSTRACT An occult, laterocervical papillary thyroid carcinoma tissue was found in a functional neck dissection for larynx cancer. The patient was a 76-year-old man with a history of smoking and alcohol ingestion who presented with a supraglottic carcinoma of the larynx located at the laryngeal surface of the epiglottis, left aryepiglottic fold, band and left ventricle with extension to the left vocal cord. Light microscopy showed a lymph node with a fibrous stroma with lymphoid follicles that presented a total substitution of the parenchyma by a papillary thyroid carcinoma. Although examination of the thyroid gland by seriated sections did not reveal any neoplasm, we argue that the papillary thyroid tissue is metastatic.
- [show abstract] [hide abstract]
ABSTRACT: Occult carcinoma of the thyroid (OCT) seems to be present in a significant proportion of the general population. Previous studies have shown large variations in the prevalence rate of OCT, which may be due to differences in the prevalence rates between different geographic areas, but also to the lack of standardized diagnostic criteria and methods of examination. The epidemiologic features of OCT at autopsy in Spain are reported for the first time. To investigate the influence of methodology in the results, two series were studied, each one using a different method. In Series A, 625 cases were studied, and sections were taken only from grossly visible lesions. In Series B, the whole thyroid glands of 100 autopsies were cut into blocks and all blocks were histologically studied. In addition, immunocytochemical stainings were performed in Series B for calcitonin, thyroglobulin, and epidermal keratin. Series A found 33 OCTs (5.28%), consisting of 29 occult papillary carcinomas (OPC), 2 occult follicular carcinomas, 1 occult oxyphilic carcinoma, and 1 occult medullary carcinoma. Series B found 22 OPC cases (22%) containing a total of 53 tumor foci. Tumor diameter varied from 0.07 to 1.8 mm. The epithelial cells of all the OPC were negative for calcitonin, weakly positive for thyroglobulin, and intensely positive for epidermal keratin. One case had metastasis in a regional lymph node. This study shows that the differences in the incidence of OCT found in numerous studies are due not only to actual different geographic incidences but also to the method of study.Cancer 07/1993; 71(12):4022-9. · 5.20 Impact Factor
- Cancer 05/1970; 25(4):803-11. · 5.20 Impact Factor
- [show abstract] [hide abstract]
ABSTRACT: Although the survival rates reported for patients with larynx carcinoma are quite good, there is a risk of developing second malignant tumors (SMT) in this population. The prognosis for SMT is poor, particularly with tumors of the lung and esophagus. The Rochester series was analyzed for larynx stage and specific SMT sites, possible common etiologic factors, and survival of the population as a whole, as well as for the SMT group. From a total of 235 patients with larynx carcinoma and a median follow-up of 10 years, 50 patients with 61 SMT were identified. The overall incidence of developing a SMT was 21%, with 44% of the SMT in the lung. The median survival from SMT diagnosis was 8.74 months and the 2-year survival was only 26%. More than twice as many SMT were observed than would be expected in the population at risk, with an observed-to-expected ratio (OER) for lung SMT of 5.3, and 8 times as many head and neck SMT occurring in our population. These SMT are not treatment related but are most likely caused by a combination of exposure to a common carcinogen, that is, tobacco smoke and alcohol, and to inherent factors, notably "condemned mucosa syndrome." Follow-up procedures, from the perspective of SMT development in larynx cancer patients, are addressed in an attempt to improve survival. The focus of this study is the high incidence of lung primaries that could be mistaken for metastatic disease, which is relatively uncommon in early larynx cancer patients.International Journal of Radiation OncologyBiologyPhysics 10/1989; 17(3):457-65. · 4.52 Impact Factor